Evidence map›Paper›PMID 19389839›Full record

ArticleJournal of the American Society of Nephrology : JASN2009

Microvesicles from mesenchymal stromal cells protect against acute kidney injury.

Joseph V Bonventre

Abstract readCommentEditorial
PubMed Publisher
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Extracellular vesicles in renal disease.Nature reviews. Nephrology · 2017
    Review
  6. Article
  7. Diverging Concepts and Novel Perspectives in Regenerative Medicine.International journal of molecular sciences · 2017
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

Joseph V Bonventre

Funding

Mechanisms of Ischemic Kidney Injury and RepairR01DK039773 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI JOSEPH VINCENT BONVENTRE · 1987 to 2026
$6.2M
Mechanisms of Ischemic Kidney Injury and RepairR37DK039773 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI BONVENTRE, JOSEPH VINCENT · 1993 to 2021
$5.2M
Biomarkers in Acute Kidney InjuryR33DK074099 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI BONVENTRE, JOSEPH VINCENT · 2007 to 2009
$1.9M
Biomarkers in Acute Kidney InjuryR21DK074099 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI BONVENTRE, JOSEPH VINCENT · 2005 to 2006
$516k
NIDDK NIH HHS DK39773NIDDK NIH HHS DK72831NIDDK NIH HHS DK74099
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Acute DiseaseCell DivisionCell TransplantationClinical Trials, Phase I as TopicCytoplasmic VesiclesEpithelial CellsGene Transfer TechniquesHumansKidney TubulesMesodermStromal Cells

Identifiers

PMID19389839

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.